Healthtech Startups

FORMEL SKIN is a telemedicine platform that provides personalized skincare treatments developed by dermatologists based on photo-based skin analysis. Customers receive customized three-product skincare routines with ongoing medical consultation via chat.

3 investors

3 investors

Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas. The company is backed by multiple life sciences investment firms and operates from San Diego.

3 investors

Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries. The company combines scientific research with global partnerships to expand patient access to treatments.

3 investors

FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors. Its work centers on cancer therapeutics developed by a team with pharma and biotech backgrounds.

3 investors

Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms. The company serves patients and the physician community seeking alternatives to lifelong pharmaceutical treatments.

3 investors

Freespira develops an FDA-indicated medical device combined with clinical support for treating PTSD and panic disorder symptoms at home over 28 days. The solution serves health plans, healthcare providers, and self-insured employers seeking to improve patient outcomes and optimize healthcare resource utilization.

3 investors

FrontrowMD is a platform that helps consumers discover and purchase health and wellness products with guidance from medical professionals. The service connects shoppers to expert opinions at the point of purchase, targeting direct-to-consumer health brands and their customers.

3 investors

Fuse uses AI and automation to provide price transparency in US healthcare by determining accurate insurance benefits, detecting underpayments, and delivering cost estimates to patients before treatment. The company serves healthcare providers and patients seeking clarity on medical costs and payment accuracy.

3 investors

FutureClinic provides direct messaging access to licensed U.S. doctors for ongoing personal healthcare at a fixed monthly subscription price, with AI-assisted intake to reduce administrative burden and ensure unbiased medical advice. The platform connects patients with doctors across 40+ specialties in 28 states and Washington, D.C.

3 investors

GAIA BioMedicine (株式会社ガイアバイオメディシン) develops GAIA-NK, a cell therapy using engineered cells with high cytotoxic activity against solid tumors, based on research from Kyushu University. The company researches, develops, and manufactures regenerative medicine products aimed at curative cancer treatment.

3 investors

Garner uses a large U.S. medical claims database to identify high-performing doctors and help employees find top in-network providers, offering a benefit that reimburses out-of-pocket medical costs. It serves employers, benefits consultants, and health plans seeking to improve care quality and reduce healthcare spending.

3 investors

Gather Health provides primary care services with integrated social and home-based support for older adults in underserved communities. The company operates physical centers that combine medical care with community programs focused on connection, education, and wellness.

3 investors

Gelatex Technologies develops nanofiber production technology for use in food production, medical applications, and sustainable materials. The company focuses on creating materials with lower environmental impact across multiple industrial sectors.

3 investors

GEM makes whole-food nutritional supplements in the form of plant-based bites designed to address nutrient deficiencies using real food ingredients rather than isolated vitamins. The products are formulated by a team of scientists and doctors using integrative and functional medicine principles, targeting consumers seeking natural wellness solutions.

3 investors

Gen1e builds healthcare solutions supported by a network of physicians across hospitals and medical centers.

3 investors

Skyline Therapeutics develops gene therapy vector technology and supports clinical development for therapeutic applications using genetic science approaches.

3 investors

Genemod offers a lab management platform that combines electronic lab notebook (ELN), LIMS, inventory, and equipment tracking in one data model, with AI agents that plan experiments, execute protocols across connected systems, and generate audit-ready records. It serves scientific research teams ranging from discovery labs to regulated manufacturing, including protein therapeutics, cell line development, strain design, and academic labs.

3 investors

Genie Fertility develops a discovery platform that uses machine learning and multi-omics analysis to identify molecular biomarkers in uterine lining, leveraging menstrual blood samples to improve reproductive health outcomes and fertility diagnostics. The platform aims to address the high failure rate of IVF by providing better understanding of endometrial health, which can account for up to one-quarter of infertility issues.

3 investors

Gennev is a telehealth clinic focused on menopause care, offering video appointments with board-certified, menopause-trained doctors and evidence-based treatment for women from perimenopause through post-menopause. It provides symptom relief, medical questionnaires, and insurance-based payment options.

3 investors

GenomeUp develops JuliaOmix™, an integrated software suite for genetic diagnostics covering patient management, sample tracking, genomic data analysis, and secure storage. It serves laboratories, research institutes, and healthcare facilities across Italy and Europe.

3 investors

Genomic Health develops diagnostic tests and related services and runs health-equity initiatives aimed at improving access, awareness, and outcomes for patients and communities, including uninsured and underinsured populations. The company focuses on making its tests inclusive through diverse clinical trials, patient education, and community partnerships.

3 investors

Getlabs provides at-home lab sample collection, sending phlebotomists to patients to draw blood and collect samples for lab tests ordered by their providers. Lab results are shared directly with the patient and the ordering provider, with support for connecting results to the Apple Health app.

3 investors

Get Well provides patient and family engagement technology for healthcare providers, now combined with RhythmX AI to bring AI capabilities to its offerings. The company operates in the digital health and patient engagement space.

3 investors